Literature DB >> 15902829

Penetrating aortic ulcers after absorption of intramural hematoma.

Enrico Aidala1, Gianluca Bardi, Richard G Ohye.   

Abstract

We report a case of a type B aortic intramural hematoma, which rapidly expanded, with ulcer-like projections, after complete absorption of the hematoma. One month after the initial presentation, a new computed tomographic scan showed the appearance of a thin ulcer-like projection in the aortic wall. Three months later, after the patient reported a new episode of chest pain, a computed tomographic scan revealed 2 penetrating ulcers and rapid aortic dilation; the aortic hematoma had been completely absorbed. Urgent thoracic aortic replacement was undertaken. Three years postoperatively, the patient was asymptomatic, with no lesion or dilation of the aorta upon computed tomography. After an acute hematoma, the strength and structure of the aortic wall can alter rapidly. Damage and weakening of the aortic wall are caused mainly by infiltration of inflammatory cells, which have pronounced proteolytic and elastolytic activity. Due to the unstable nature of the lesion, optimal management remains controversial. In our patient, the inflammatory process led to the development of 2 aortic ulcers and aortic dilation within 3 months of the acute lesion, requiring urgent surgical intervention.

Entities:  

Mesh:

Year:  2005        PMID: 15902829      PMCID: PMC555831     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  15 in total

1.  Aortic blebs: possible site of aneurysm rupture.

Authors:  G C Hunter; S C Leong; G S Yu; K E McIntyre; V M Bernhard
Journal:  J Vasc Surg       Date:  1989-07       Impact factor: 4.268

2.  Acute aortic dissection with intramural hematoma: possibility of transition to classic dissection or aneurysm.

Authors:  K Ide; H Uchida; H Otsuji; K Nishimine; J Tsushima; H Ohishi; S Kitamura
Journal:  J Thorac Imaging       Date:  1996       Impact factor: 3.000

3.  Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan's syndrome.

Authors:  J Shores; K R Berger; E A Murphy; R E Pyeritz
Journal:  N Engl J Med       Date:  1994-05-12       Impact factor: 91.245

4.  Different clinical features of aortic intramural hematoma versus dissection involving the ascending aorta.

Authors:  J K Song; H S Kim; D H Kang; T H Lim; M G Song; S W Park; S J Park
Journal:  J Am Coll Cardiol       Date:  2001-05       Impact factor: 24.094

5.  Intramural hematoma of the aorta: predictors of progression to dissection and rupture.

Authors:  Yskert von Kodolitsch; Susanne K Csösz; Dietmar H Koschyk; Ilka Schalwat; Roger Loose; Matthias Karck; Christoph Dieckmann; Rossella Fattori; Axel Haverich; Jürgen Berger; Thomas Meinertz; Christoph A Nienaber
Journal:  Circulation       Date:  2003-03-04       Impact factor: 29.690

6.  New development of an ulcerlike projection in aortic intramural hematoma: CT evaluation.

Authors:  Eijun Sueyoshi; Yohjiro Matsuoka; Tatsuya Imada; Tomoaki Okimoto; Ichiro Sakamoto; Kuniaki Hayashi
Journal:  Radiology       Date:  2002-08       Impact factor: 11.105

7.  Penetrating atherosclerotic ulcer of the descending thoracic aorta and arch.

Authors:  Kwang Ree Cho; Anthony W Stanson; D Donald Potter; Kenneth J Cherry; Hartzell V Schaff; Thoralf M Sundt
Journal:  J Thorac Cardiovasc Surg       Date:  2004-05       Impact factor: 5.209

Review 8.  Morphology of small aneurysms: definition and impact on risk of rupture.

Authors:  G L Faggioli; A Stella; M Gargiulo; S Tarantini; M D'Addato; J J Ricotta
Journal:  Am J Surg       Date:  1994-08       Impact factor: 2.565

Review 9.  Penetrating atherosclerotic aortic ulcers.

Authors:  H D Movsowitz; C Lampert; L E Jacobs; M N Kotler
Journal:  Am Heart J       Date:  1994-12       Impact factor: 4.749

10.  Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm.

Authors:  T Freestone; R J Turner; A Coady; D J Higman; R M Greenhalgh; J T Powell
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-08       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.